The regulatory file for calcium L-aspartate
The file starts with the exact material: calcium L-aspartate, its composition and calcium figure, the specification revision and the lot certificate. The destination route, the permitted-source question, the contaminant limits and the label are separate checks, and the buyer's regulatory team confirms them for the market where the finished product is sold. This page lists the documents and the questions that belong in that file; it does not decide the route.
The specification describes the powder, the certificate describes the lot, and the regulatory file has to show that both fit the destination and the label.
What the file contains
A complete file answers four practical questions. What is the material, and which specification revision is being bought? Which lot is being released, and what does its certificate report? Which source, contaminant and label rules apply to the finished product in the destination? And what changes if the source, the process or the pack changes?
The certificate answers the lot question, the technical data sheet answers the specification question, and the safety data sheet answers the handling question. None of them answers the route question on its own. The file should also hold the allergen and GMO statements, the origin record, the residual-solvent statement and any customer-specific declaration.
Keep a version list. A folder of undated PDFs is not a regulatory file; a table that names each document, its version, its date and the specification revision it supports is. Where a statement is not available for the lot, name the gap before the order rather than discovering it at the port.
European Union
The EU file is built from the specification, the contaminant results and the label. General food law under Regulation (EC) No 178/2002 applies, and food supplements are placed under Directive 2002/46/EC, whose Annex II lists permitted vitamin and mineral sources. Labelling follows Regulation (EU) No 1169/2011, contaminants follow Regulation (EU) 2023/915, and claims follow Regulation (EC) No 1924/2006. If the ingredient is added to a food rather than supplied as a supplement, Regulation (EC) No 1925/2006 may be the relevant addition instrument.
The permitted-source list names specific calcium salts. The buyer's regulatory team checks whether the aspartate form is named for the destination, and whether another route, including the novel-food framework of Regulation (EU) 2015/2283, applies. This page does not assert that the material is authorised or permitted in any market; that determination belongs to the buyer's team, with the current consolidated text as the reference.
Great Britain and Northern Ireland are checked separately. The GB file uses the retained GB rules and register, while Northern Ireland follows the EU framework. The destination decides which file applies.
United States
The US file is built around the exact dietary ingredient and its intended use. A dietary supplement is placed under the DSHEA framework, with current good manufacturing practice in 21 CFR Part 111 and the Supplement Facts panel in 21 CFR 101.36. If the ingredient has not been marketed in the US before, the new dietary ingredient notification route in 21 CFR 190.6 may apply; the buyer's team confirms the basis and the evidence.
Structure and function statements are governed by 21 CFR 101.93 and require the disclaimer; disease claims are not permitted. FDA does not approve a supplement or its label before sale, so the absence of an objection is not an approval. The label and the claim are reviewed separately from the certificate.
Contaminants and limits
The contaminant panel is a finished-product calculation, not only a drum result. The table below is the usual starting point for a food-supplement file; the current destination text and the daily dose decide the final limit. The specification limits on the certificate and the regulatory limit on the finished product are different gates, and the lower of the two governs the purchase.
| Parameter | Typical supplement reference | What the file should show |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | Lot result, method, limit and the finished-product calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | Lot result and any category exception that applies |
| Mercury (Hg) | 0.10 mg/kg in the supplement | Lot result and method |
| Arsenic (As) | Customer or market limit | The agreed limit and the method, stated on the certificate |
The calculation runs from the as-is calcium figure and the daily dose. A supplement that delivers 500 mg calcium from this salt carries about 3.8 g of the ingredient, so a lead result in mg/kg is multiplied by that mass, not by the capsule weight. The heavy-metals entry sets out the panel and the methods.
Label and claims
The label names the material, the quantity and the source in the form the destination requires. The claim review is separate: the brand's regulatory reviewer confirms that the wording is allowed for the product, the form and the market. A nutrient content or health claim has to come from the authorised list, meet its conditions and use the permitted wording. The certificate does not approve a claim, and a claim does not change the specification.
This page makes no claim about the ingredient. It describes a specification, a certificate and a file. It is not a label text, and the editorial policy explains how the technical pages are kept separate from marketing wording. The grade page covers the composition choice that the label has to name.
Documents in the file
| Document | Question it answers | What to check |
|---|---|---|
| Specification | What is being bought? | Composition, formula, calcium window, assay basis, mesh |
| Batch COA | What was released? | Lot, methods, results, limits and the identity evidence |
| Technical data sheet | How does the grade behave? | Solubility, pH, water, particle size and storage |
| Safety data sheet | How is it handled? | Hazard, dust, storage and transport information |
| Declarations | Does it fit the market? | Allergen, GMO, origin, residual solvents and change control |
Checklist before the first order
- The composition, formula and specification revision are named.
- The calcium and assay results are reported on stated bases.
- COA, TDS, SDS, allergen, GMO, origin and residual-solvent statements are on file.
- The contaminant results are converted to the finished-product dose.
- The destination route and the label wording have been reviewed by the buyer's team.
- The source, process and pack are under change control.
- The quotation, the specification and the certificate refer to the same version.
The product hub carries the catalog specification; the COA page explains the lot certificate; the identity page covers the analytical evidence; the EU regulatory notes and the US notes give the framework; the quality page describes the release file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation